CytoAgents has filed a notice of an exempt offering of securities to raise $15,204,008.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, CytoAgents is raising $15,204,008.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Teresa Whalen played a key role in…
